Next, we studied possible causes of mTNFα expression impairment ultimately leading to a selective defect in TNFα-mediated cytotoxic function of IFN-DCs from patients with high-grade gliomas against autologous tumor cells. The gene discussed is IFNA1; the disease is central nervous system cancer.